(Q44638547)

4 December 2017

title

Efficacy and safety of modafinil for improving daytime wakefulness in patients treated previously with psychostimulants (English)

1 reference

4 December 2017

1 reference

John Harsh

4

1 reference

4 December 2017

Jonathan R. L. Schwartz

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592359

27 March 2024

Neil T. Feldman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592359

27 March 2024

June M. Fry

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592359

27 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14592359

27 March 2024

publication date

1 January 2003

1 reference

4 December 2017

number of pages

7

1 reference

full work available at URL

inferred from page(s)

https://api.elsevier.com/content/article/PII:S138994570200240X?httpAccept=text/xml

1 reference

10.1016/S1389-9457(02)00240-X

DOI

https://api.crossref.org/works/10.1016/S1389-9457(02)00240-X

https://api.elsevier.com/content/article/PII:S138994570200240X?httpAccept=text/plain

27 March 2024

1 reference

10.1016/S1389-9457(02)00240-X

DOI

https://api.crossref.org/works/10.1016/S1389-9457(02)00240-X

27 March 2024

1 reference

4 December 2017

volume

4

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

43-49

1 reference

Evaluation of treatment with stimulants in narcolepsy.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

Amphetamines: pharmacology, abuse and addiction

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

Hypothalamic arousal regions are activated during modafinil-induced wakefulness.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

Effects of modafinil on symptomatology of human narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

Use of modafinil in the treatment of narcolepsy: a long term follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

Modafinil in obstructive sleep apnea-hypopnea syndrome: a pilot study in 6 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of residual excessive daytime sleepiness in the sleep apnea/hypopnea syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

Practice parameters for the use of laser-assisted uvulopalatoplasty: an update for 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

Problems associated with switch to modafinil - a novel alerting agent in narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900240-X

7 January 2021

10.1016/S1389-9457(02)00240-X

Identifiers

DOI

1 reference

4 December 2017

1 reference